January 2, 1997Open Access
View Full PaperHow European cardiologists perceive the role of calcium antagonists in follow-up after myocardial infarction
Key Result
Calcium antagonists were viewed by about 100 European cardiologists as an alternative to beta-blockers post-myocardial infarction, but should be avoided in patients with left ventricular failure.
Structured PICO
P
Population
About 100 European cardiologists discussing follow-up management of patients after myocardial infarction
I
Intervention
Calcium antagonists (non-dihydropyridine)
European cardiologists agree that non-dihydropyridine calcium antagonists are an alternative to beta-blockers for post-MI management when beta-blockers are contraindicated, provided there is no left ventricular failure.
Abstract
About one hundred European cardiologists discussed the role of calcium antagonists in the follow-up management of myocardial infarction. beta-blockers are the treatment of choice. Where these are contra-indicated or otherwise unsuitable, many clinicians would use a non-dihydropyridine calcium antagonist alone or in combination with an ACE inhibitor. There is broad agreement that calcium antagonists should not be used in patients with concomitant left ventricular failure. Cholesterol estimation in post-infarction patients is essential.